Weiss, Anna
Agnese, Doreen M.
Al-Hilli, Zahraa
Cabioglu, Neslihan
Farr, Deborah
Kantor, Olga
Obeng-Gyasi, Samilia
Wilke, Lee
Article History
Received: 17 February 2025
Accepted: 14 April 2025
First Online: 12 May 2025
Change Date: 21 May 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1245/s10434-025-17580-7
Disclosure
: AW reports paid advisory board participation for Abbvie, Merck, and Myriad. She has received honoraria from OncLive (MJH Lifesciences), Empire State Hematology & Oncology Society, Society of Breast Imaging. DA Nothing to disclose. ZA Nothing to disclose. NC Nothing to disclose. DF Nothing to disclose. OK Nothing to disclose. SOG Nothing to disclose. LW Founder and Minority Stock Owner; Elucent Medical; Principal Investigator Perimeter Medical ( no salary support).